Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
3
×
detroit blog main
detroit top stories
glaxosmithkline
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
3
×
wisconsin top stories
alzheimer's disease
clinical trials
crispr
eli lilly
merck
multiple myeloma
multiple sclerosis
opioid
startups
acceleron pharma
What
bio
3
×
roundup
companies
abbvie’s
approval
barbecuing
biogen’s
biopharmaceutical
black
camping
cardiologist
center
check
cholesterol
conference
continue
convo
day
debut
diamond
diamond’s
drug
earlier
failures
flop
hit
indication
j
j’s
labor
leading
life
littered
mammoth
march
monday
moves
nash
new
news
Language
unset
Current search:
glaxosmithkline
×
bio
×
" wisconsin blog main "
×
abbvie
×
cancer
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More